Lion Point Capital’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-82,425
Closed -$1.95M 35
2023
Q4
$1.95M Hold
82,425
0.97% 10
2023
Q3
$1.23M Sell
82,425
-17,000
-17% -$253K 0.55% 11
2023
Q2
$1.09M Hold
99,425
0.49% 14
2023
Q1
$867K Sell
99,425
-120,000
-55% -$1.05M 0.36% 20
2022
Q4
$704K Hold
219,425
0.1% 22
2022
Q3
$704K Buy
+219,425
New +$704K 0.16% 25